单唾液酸四己糖神经节苷酯治疗新生儿缺氧缺血性脑病的效果观察被引量：1

在线阅读下载PDF

导出

摘要目的:探讨单唾液酸四己糖神经节苷酯治疗新生儿缺氧缺血性脑病的效果观察。方法:将我院收治的缺氧缺血性脑病患儿50例随机分为2组观察组和对照组各25例。观察组在常规治疗的基础上,给予单唾液酸四己糖神经节苷酯治疗,对照组在常规治疗的基础上给予脑活素治疗,比较2组患儿的临床疗效。结果:观察组的总有效率为100%,对照组的总有效率为56%,观察组的总有效率明显优于对照组,2组比较,差异具有统计学意义(P<0.05)。结论:单唾液酸四己糖神经节苷酯治疗新生儿缺氧缺血性脑病的临床效果显著优于脑活素治疗效果,有利于疾病在急性期的快速恢复,缩短病程,提高患儿的生存质量,降低致死率和死亡率,值得临床推广应用。

作者房辉

机构地区山东省夏津县人民医院小儿科

出处《中国伤残医学》 2012年第9期64-66,共3页 Chinese Journal of Trauma and Disability Medicine

关键词单唾液酸四己糖神经节苷酯新生儿缺氧缺血性脑病临床疗效

分类号 R722 [医药卫生—儿科]

引文网络
相关文献

参考文献2

1郑磊,邵斌,任艳丽,胡生海.单唾液酸四己糖神经节苷酯治疗新生儿缺氧缺血性脑病90例[J].中国实用神经疾病杂志,2008,11(7):54-55. 被引量：27
2高丽芳,陈光明.新生儿缺氧缺血性脑病的中西医治疗现状[J].中国中医急症,2012,21(2):265-266. 被引量：10

二级参考文献27

1韩玉昆.新生儿缺氧缺血性脑病诊断依据和临床分度[J].中华儿科杂志,1997,35(2):99-100. 被引量：2786
2[5]鲍秀兰,主编.新生儿行为和0～3岁教育[M].北京:中国协和医科大学出版社,1998.46-55.
3Dussaule JC,chatziantoniou C. Reversal of renal disease:Is it enough to inhibit the action of angiotensin 1I [J]. Cell Death Differ, 2007,14 (7) :1343-1349.
4Kim SS,Lee KH,Sung DK,et al. Erythropoietin attenuates brain in- jury,sub-entricular zone expansion, and sensorimotor deficits in hy- poxic-ischemic neonatal rats[J ]. J Korean Med Sci, 2008,23 (3) :484- 491.
5Taoufik E, Petit E, Divoux D, et al. TNF receptor I sensitizes neurons to er-ythropoietin and VEGF-mediated neuroprotection after ischemic and excitotoxic injury [J ]. Proc Natl Acad Sci USA, 2008,105 (16): 6185-6190.
6Fred H. Molecular and cellular mechanisms contributing to the regula- tion,proliferation and diferentiation of neural stem cellsinthe adult dentate gyms[J]. Keio J Med,2010,59(3) :79-83.
7Degos V,Lomn G, Mantz J,et al. Neuropmteetive strategies for the neonatal brain [ J 1. Anesth Analg, 2008,106 ( 6 ) : 1670-1680.
8Banks P, Franks NP, Dicknson R. Competitive inhibition at the glycine site of the Nmethyl-D-aspartate receptor mediates xenon neuroprotec- tion against hypoxia-ischemia [ J ]. Anesthesiology, 2010,112 ( 3 ) : 614-622.
9Matchett GA,Allard MW,Martin RD,et al. Neuroprotective effect of volatile anesthetic agents :molecular mechanisms [J ]. Neurol Res,2009, 31 (2) : 128-134.
10Limatola V,Ward P, Catrand D, et al. Xenon preconditioning confers neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion [J ]. Neuroscience, 2010,165 (3): 874-881.